Classic Benjamin Graham Stock Screener
Free Value Investing for Intelligent Investors across Global Equity Markets, as recommended by Warren Buffett.
| Company Name | MIC | HQ | Fiscal Year | Last Updated | Curr Code | Previous Close | Graham Number | Graham Number(%) | NCAV/ NetNet | NCAV/ NetNet(%) | Graham Grade | Intrinsic Value | Intrinsic Value(%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 381 | Sobr Safe Inc (SOBR) | XNAS | US | 2024-12-31 | 19 hours ago | USD | 1.50 | 0.00 | 0.00% | 80.32 | 5,354.61% | Ungraded | 0.00 | 0.00% |
| 382 | Kandi Technologies Group Inc (KNDI) | XNAS | CN | 2024-12-31 | 19 hours ago | USD | 0.98 | 0.00 | 0.00% | 2.66 | 271.31% | Ungraded | 0.00 | 0.00% |
| 383 | Enveric Biosciences Inc (ENVB) | XNAS | US | 2024-12-31 | 19 hours ago | USD | 5.36 | 0.00 | 0.00% | 3,720.00 | 69,402.99% | Ungraded | 0.00 | 0.00% |
| 384 | Neoleukin Therapeutics Inc (NLTX) | XNAS | US | 2022-12-31 | 1 year ago | USD | 15.10 | 0.00 | 0.00% | 227.94 | 1,509.54% | Ungraded | 0.00 | 0.00% |
| 385 | Incannex Healthcare Inc (IXHL) | XNAS | AU | 2024-06-30 | 19 hours ago | USD | 0.39 | 0.00 | 0.00% | 0.65 | 167.55% | Ungraded | 0.00 | 0.00% |
| 386 | Hubei Minkang Pharmaceutical Ltd (HBMK) | SG | 2013-12-31 | 3 years ago | USD | 0.01 | 0.13 | 1,284.52% | 0.08 | 844.99% | Ungraded | 0.00 | 0.00% | |
| 387 | Aeglea Bio Therapeutics Inc (AGLE) | XNAS | US | 2022-12-31 | 2 years ago | USD | 11.04 | 0.00 | 0.00% | 399.04 | 3,614.48% | Ungraded | 0.00 | 0.00% |
| 388 | Quantum Biopharma Ltd (QNTM) | XNAS | CA | 2022-12-31 | 19 hours ago | USD | 7.75 | 0.00 | 0.00% | 16.92 | 218.26% | Ungraded | 0.00 | 0.00% |
| 389 | Reneo Pharmaceuticals Inc (RPHM) | XNAS | US | 2023-12-31 | 1 year ago | USD | 1.65 | 0.00 | 0.00% | 2.63 | 159.20% | Ungraded | 0.00 | 0.00% |
| 390 | Vislink Technologies Inc (VISL) | OOTC | US | 2024-12-31 | 19 hours ago | USD | 2.20 | 0.00 | 0.00% | 5.00 | 227.27% | Ungraded | 0.00 | 0.00% |